BLCO may be sold in 2025 to service the debt of majority shareholder BHC, and any sale will be at a premium to the current ...

Duquesne Family Office's billionaire chief shed a trillion-dollar artificial intelligence (AI) stock in favor of a ...

he orchestrated its $8.7 billion sale to Valeant Pharmaceuticals. He then took over as the CEO of Forest Laboratories. By February 2014, Saunders orchestrated the sale of the company to Actavis ...

In May 2013, during his first run as the CEO of Bausch and Lomb, he orchestrated its $8.7 billion sale to Valeant ...

Feb 19 (Reuters) - An index of Indian pharmaceutical company shares (.NIPHARM), opens new tab slid 2% to its lowest level in seven months on Wednesday after U.S. President Donald Trump said he ...

In this article, we are going to take a look at where Takeda Pharmaceutical Company Limited (NYSE:TAK) stands against the other Japanese stocks. As the dangers of natural disasters increase and ...

Those mixed emotions also show up in consumer reactions to their experiences with moving companies. Our research using Forbes Home’s Consumer Sentiment Index tool, which analyzed more than ...

Investors have taken to punishing pharma companies that appear unable to gauge demand for their top products.

Fortunately, there were no reported casualties. Trump's 'golden rule' for imposing reciprocal tariffs According to District Collector Vijaya Krishnan, an "unknown gas leakage" was reported at Hetro ...

CHATHAM, N.J., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of ...